Elevating Atopic Dermatitis Care : Episode 5

Atopic Dermatitis: Evaluating Patient Response to Therapy

June 3, 2024

Opinion

Video

Lawrence Eichenfield, MD, provides clinical insights on evaluating patient response to therapy and managing adverse effects.

EP: 1.Treatment Landscape and Clinical Burden of Atopic Dermatitis

EP: 2.Overview of Treatments for Atopic Dermatitis

EP: 3.Treatment Decisions and the Role of Systemic Therapy in Atopic Dermatitis

EP: 4.Navigating Insurance Barriers in Atopic Dermatitis

Now Viewing

EP: 5.Atopic Dermatitis: Evaluating Patient Response to Therapy

EP: 6.Future Perspectives on Atopic Dermatitis Treatment

EP: 7.Exciting Developments in Atopic Dermatitis

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Related Content

Value-Based Decision-Making in Metastatic Breast Cancer

Ian E. Krop, MD, PhD;Debra Patt, MD, PhD, MBA

September 16th 2021

Article

In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.